- DOJ seeks immediate asset freeze, receivership against telehealth company Zealthy
- New Clues Explain Why Immunotherapy Fails in Pancreatic Cancer
- Does My Child Have a Language Disorder?
- Journalists Talk Hot Health Topics: Urgent Care Clinics Performing Abortions and Doulas’ Pay
- ASCs’ vendor problem
- Providence’s physician chief on its ‘holistic’ approach to value-based care
- What the Health? From KFF Health News: A New CDC Nominee, Again
- States Update Guardianship Laws To Keep Children of Immigrants Out of Foster Care
- Anesthesia job market faces ‘major disruption’
- Florida system raises $100M for new ED
- North Carolina system names COO
- Mark Cuban wants to bring drug manufacturing to hospitals’ doorsteps — literally
- UCI Health names chief AI officer
- Nevada hospital names CEO
- Saint Luke’s taps president for 2 hospitals
- Dental community mourns dentist killed in murder-suicide
- Mass General Brigham, CVS deal could raise healthcare spending $40M annually: Report
- Ideal Dental opens 1st Oklahoma practice, expands in 2 more states
- PDS Health eyes the next era of medical-dental integration
- Mark Cuban dives into direct contracting
- HCA executive pay by the numbers
- Iris Telehealth offers behavioral health analytics platform
- HHS names chief economist, regulatory leader to address healthcare affordability
- Loma Linda University Health names new president
- The best ASCs for colonoscopy, endoscopy in the South: US News
- Tennessee moves forward with CON repeal
- Dental schools take action to alleviate workforce shortages: 6 updates
- American Medical Group Association partners with Talkiatry to expand psych access
- Trump nominates CDC director
- ChristianaCare, Cardiovascular Physicians of Delaware to open joint venture ASC
- 5 states regulating AI in mental health
- Centerstone debuts $13M youth behavioral health campus in Missouri
- 3 DSOs making headlines
- Maine restricts noncompetes for rural healthcare workers
- Heartland Dental opens Florida office
- The 10 biggest ASC deals of the last 5 years
- Affordability, transparency: A look at large employers' top healthcare concerns
- 10 dental Medicaid updates to know from Q1
- White House eyes ibogaine research expansion
- New Weight Loss Research Questions Need for GLP-1 Drugs
- Trump Names CDC Director Pick
- SocialRx teams up with FQHC in NYC to prescribe arts and culture for chronically ill patients
- FDA To Review Whether To Allow More Access To Certain Peptides
- Rising Colon Cancer Deaths Hit Younger Adults Without Degrees Hardest
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- The Healthccare Burnout Backlask (pt 4): Why Contract Negotiation Has Become a Core Strategic Skill for Healthcare Administrators
- Over 80% of PCPs concerned about financial stability over next several years
- Industry Voices—DOJ jumps into 340B cases over state law, raising questions about federal plans for the program
- FDA's accelerated approval pathway needs stronger transparency, evidence standards: ICER
- Most People Would Take A Blood Test For Alzheimer's, Study Says
- This Sexually Transmitted Infection Linked To Heart Attack, Stroke
- How Playtime at Age 2, Especially with Parents, Shapes Teen Fitness Habits
- New Depression Treatment Matches ECT with Less Memory Loss, Study Says
- Memory Problems? Your Salt Intake Could Make Matters Worse, Study Says
- Ultra-Processed Foods Linked To Fatty Muscles, Potential Knee Arthritis
- Your New Therapist: Chatty, Leaky, and Hardly Human
- Teva scores in appeal as court revives $177M verdict against Lilly in migraine patent spat
- Gen AI chatbots continually struggle with differential diagnoses, Mass General Brigham study finds
- Listen: With Little Federal Regulation, States Are Left To Shape the Rules on AI in Health Care
- Fierce Pharma Asia—Astellas’ stem cell therapy rethink; GSK’s bullish ADC plan; Daiichi’s OTC sale
- BIO comes out swinging with 'Fight of Our Lives' campaign for the industry’s 50th birthday
- The future of medical-dental integration is here
- Texas dentist has license suspended
- Efforts grow to limit corporate dental ownership, protect dentist autonomy: 6 updates
- What’s the deal with insurer mental health parity violations?
- Remarks at the Options Market Structure Roundtable
- Wider care gaps predicted as mental health parity rule faces rollback
- Sheppard Pratt gets $16.5M for behavioral health expansion
- Former Deputy Surgeon General Erica Schwartz, M.D., nominated as CDC director
- Verily Health simplifies medical jargon alphabet soup with AI-powered app in new campaign
- 10 trends in behavioral health usage: Report
- Cattywampus: Statement on the CAT Concept Release
- Providers' advantage on out-of-network billing disputes likely to continue: Capstone
- Butterflies and Condors: Remarks at the Options Market Roundtable
- Viatris, Teva kick off separate recalls over dissolution, raw material issues
- Mental health ED visits at Children’s Hospital Colorado jump 20% in April
- Rising ACA Costs Leave Many Unable To Pay for Coverage
- One Lot of Xanax Recalled Nationwide Over Quality Issue, FDA Says
- Cough Drops From Several Brands Being Recalled, FDA Says
- CDC May Get New Leader as Officials Consider Erica Schwartz
- Statement at the Roundtable on Options
- Opening Remarks at the Options Market Structure Roundtable
- APA launches resource library for trusted digital mental health tools
- E-Bikes And E-Scooters A Growing Menace On City Streets, Study Says
- 'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
- RFK Jr. kicks off string of congressional hearings to talk White House budget plan
- This Simple Step Could Improve The Benefits From Your Regular Workouts
- New Alzheimer's Drugs Provide No Meaningful Benefit, Major Evidence Review Concludes
- Air Pollution and Weather Tied to Migraines
- Study Says Stress, Weight And Hormones Alter Timing of Puberty in Girls
- Why Walking Remains Unsteady After Partial Spinal Cord Injury
- Roche to launch another Elevidys study after EU rejection of Duchenne gene therapy
- Lilly answers FDA's call for more Foundayo safety info, plotting diabetes filing in parallel
- New Federal Medicaid Rules Require One Month of Work. Some States Demand More.
- As US Birth Rate Falls, Feds’ Response May Make Pregnancy More Dangerous
- Omnicom brews Olixir from FCB Health, rebranding storied agency after Interpublic takeover
- DiMe-led initiative brings together pharma, virtual providers, digital pharmacies to develop blueprint for DTC pharma models
- UPDATED: Heeding RFK Jr.'s call, FDA reclassifies 12 unapproved peptides ahead of advisory committee meeting
- Carrot launches proprietary AI platform for personalized fertility, family care
- UC Health workers plan open-ended, system-wide strike for May 14
- Baylor Scott & White Health Plan to depart individual market, Medicaid this year
- In industry's latest OTC pivot, Daiichi Sankyo lines up $1.5B consumer health unit sale to beverage giant Suntory
- Brain Cancer Awareness: The Importance of Molecular Testing for Patients with Rare Brain Tumors
- EPA Delays Decisions on 'Forever Chemicals'
- Wildlife Trade Tied To Higher Risk of Diseases Spreading to Humans
- Yes, This is the Worst Pollen Season Ever — Until Next Year
- GoodRx launches 7.2-mg Wegovy dose for self-pay patients at $399 per month
- Progyny unveils new fertility benefit option for small, mid-size employers
- Providers back bipartisan bill eliminating Medicare chronic care management cost sharing
- New Weight Loss Pill, Foundayo, Gets Approval But FDA Seeks More Safety Data
- Seqster launches new data tool to turn clinical sites into 'research-ready data collection points'
- Gilead widens global Yeztugo access agreement, but MSF says supply is 'not nearly enough'
- Novartis CEO Vas Narasimhan joins Anthropic’s board as biopharma’s ties to AI deepen
- Behavioral health utilization is up with anxiety disorders leading demand, report finds
- Does Your Child Have A Concussion? These Are The Signs, Review Says
- AI Reveals Negative Labels in Medical Records for Sickle Cell Patients
- 'Food-as-Medicine' Improves Life for Heart Failure Patients
- Silent Heart Rhythm Problem Might Triple Risk Of Heart Failure In Seniors
- Blood Test Predicts Alzheimer's Years Before Symptoms, Brain Changes
- An Infectious Combo Triples Risk Of MS, Study Says
- Astellas manufacturing chief views reliable supply, bridging research as his production 'north star'
- Physician compensation up 3% in 2025, but not all specialties saw raises: Medscape
- Pfizer recruits former Angel Lucy Liu for latest mission against cancer
- Teva launches new online schizophrenia community project
- One man’s journey from gambling addiction to recovery and advocacy
- Medi-Cal Immigrant Enrollment Is Dropping. Researchers Point to Trump’s Policies.
- Rural Nebraska Dialysis Unit Closes Despite the State’s $219M in Rural Health Funding
- Ionis exec shares method to the Madness after 2026 Drug Name Tournament win
- Abridge expands clinical decision support solution with UpToDate partnership, new NEJM, JAMA content tie-ups
- Travere maps course for Filspari's $3B US opportunity after landmark rare disease nod
- FDA tells Eli Lilly to round up more safety info on key obesity launch Foundayo
- Meat Consumption Rises as Protein Trend Grows, Experts Warn
- Bill would force payers to apply DTC drug purchases to patient deductibles
- Nuts.com Recalls 10,000+ Pounds of Candy Over Allergy Risk
- Listen to the Latest ‘KFF Health News Minute’
- Keebler Health secures $16M in series A funding for AI-powered risk adjustment platform
- Sam’s Club Recalls Children’s Pajamas Due to Fire Hazard
- Small Talk? It May Be Better Than You Think
- J&J, chasing $100B year, sports immunology ‘dual powerhouse’ of Tremfya and new launch Icotyde
- Long-Term Opioid Prescriptions Fall By About A Quarter
- Gut Bacteria Might Drive Rare Food Allergy in Children, Study Finds
- Stents Can Ease Long-Term Symptoms Of Deep Vein Thrombosis, Trial Shows
- Young Cancer Survivors Face Doubled Risk Of Subsequent New Cancer
- Novo taps OpenAI to deploy AI across R&D, manufacturing and corporate functions
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- FDA Reminds More Than 2,200 Sponsors and Researchers to Disclose Trial Results
- Freedom of Associations
- Interfacing with our Inner Demons: Comments on the Division of Trading and Markets' Statement on Certain User Interfaces
- Staff Statement Regarding Broker-Dealer Registration of Certain User Interfaces Utilized to Prepare Transactions in Crypto Asset Securities
- Statement Regarding Staff No-Action Letter to Bank of England
Prepare for more hospital charges and insurance premium hikes.
Mandates have that effect, and much more.
What are the moral implications of requiring hospitals to offer IUDs to "certain patients"? Does this refer to Medicaid patients? If so, is such discrimination constitutional?
Thursday, September 26, 2024 1:30 p.m.
AGENDA
SB 973 Sen. Cavanagh Insurance; health insurers; coverage for certain contraception; require.
SB 974 Sen. Irwin Human services; medical services; coverage for contraception and emergency contraception; require.
SB 987 Sen. McMorrow Insurance; health insurers; coverage for inpatient long-acting reversible contraceptives; require.
SB 988 Sen. McMorrow Human services; medical services; coverage for immediate postpartum intrauterine devices and contraceptive implants and associated anesthesia services; provide for.
SB 1006 Sen. McMorrow Health facilities; hospitals; hospitals stocking intrauterine devices; require and require hospitals to offer intrauterine devices to certain patients.
And any other business properly before the committee.
Michigan Senate Bill 1006 requires that Maternity Wards of all religious affiliations stock and provide contraceptives to desiring patients.
A hospital that operates a maternity unit shall ensure that an individual who is giving birth in the hospital has the option, if not medically contraindicated, of having an intrauterine device implanted after delivery and before the individual is discharged. A hospital shall ensure that a sufficient number of intrauterine devices are in stock and available at the hospital to meet the requirements of this section.
https://www.legislature.mi.gov/documents/2023-2024/billintroduced/Senate/pdf/2024-SIB-1006.pdf
The short Bill, which was supported in its Health Policy committee meeting this past Thursday, makes no exemption for Catholic Hospitals which might have a religious dispute with furnishing contraceptives to patients. This may prove to create a dispute between the Legislature and religiously affiliated Healthcare Systems.
Meeting Notes for Thursday's committee: https://committees.senate.michigan.gov/committees/ViewDocument/?apn=2023_2024_session%2Fcommittee%2Fsenate%2Fstanding%2Fhealth_policy%2Fmeetings%2F2024-09-26-1%2Fdocuments%2Ftestimony%2FAmy%20Zaagman%20MCMCH%20Support%20SBs%20973%20974%20987%20988%201006.pdf
Lest we forget the breast cancer implications here, the risk was reiterated last week.
MedPage reports JAMA's publication of a recent Danish study.
Methodology is clipped for length, but worth reading.
https://www.medpagetoday.com/hematologyoncology/breastcancer/112451
Hormonal IUDs Linked to Increased Breast Cancer Risk
— Absolute risk remains low, however
During follow-up of almost 7 years, hormone-releasing IUD use conferred a 40% higher risk of breast cancer. The data showed a trend toward increasing risk with duration of IUD use, reaching 80% among women who reported using the devices for 10-15 years.
The differences translated into excess breast cancer diagnoses that ranged from 14 to 71 per 10,000 users, although a trend analysis proved to be nonsignificant, reported Lina Steinrud Mørch, PhD, of the Danish Cancer Institute in Copenhagen, and co-authors in JAMA.
"Given the increase in LNG-IUS [levonorgestrel intrauterine systems] among females at an age with some risk for breast cancer, and its likely long-term use, information about breast cancer risk should accompany discussions about benefits and risks," the authors stated. In a prior study, "the HR [hazard ratio] with short-term LNG-IUS use was similar to that of contraceptive pills (1.2, 95% CI 1.1-1.3)."
But that earlier research could not address the duration of continuous use, and prior studies have not adequately accounted for use of other types of hormonal contraceptives.
The new results add to existing evidence suggesting an association between hormonal contraception and breast cancer, and are consistent with a recent study showing a 29% greater relative risk for breast cancer among BRCA1 carriers who used any type of hormonal contraceptive.
To examine breast cancer risk by duration of LNG-IUS use, Mørch and colleagues queried Danish national healthcare registries to identify first-time users of LNG-IUS, ages 15-49, during 2000-2019. Users of other hormonal contraceptives within the previous 5 years were excluded.
The search identified 78,595 new users of LNG-IUS who were matched to 78,595 non-users of hormonal contraceptives. The study population had a mean age of 38. Mean duration of follow-up was 6.8 years for the entire population, including 5.9 years for the LNG-IUS users and 7.7 years for the non-users.
<clip>
It seems Gov. Whitmer was not content with the legislature's pace on these bills.
Yesterday, several news sources broke the news of her executive order mandating insurance cover birth control pills, even the over-the-counter kinds.
Quoting Fox 17 News here. MLive's story is behind paywall.
Michigan to roll out free contraceptives program next month
The state of Michigan is launching a new program in November that will guarantee free access to contraception.LANSING, Mich. — The state of Michigan is launching a new program in November that will guarantee free access to contraception.
The “Take Control of Your Birth Control” program allows participating community partners and federally qualified health centers the ability to distribute free condoms, birth control and emergency contraception to Michiganders.
Recipients will also be given information that will enable them to make informed decisions on their reproductive health.
“We always want people to know what health resources that are available, especially if health options are available for free or low cost. I think it's our duty to really educate them,” says Dr. Natasha Bagdasarian, chief medical executive at the Michigan Department of Health and Human Services. “It's our role to really make sure that people have the best information possible so that they can make decisions about their health and their bodies that work for them.”
The program lasts through November.
The state expects to publish a full list of participating organizations — and an interactive map of their locations — on its website before next Friday.
Marquette WLUC's Colin Jackson included a detail not reported elsewhere:
"Contraceptive items will be distributed until supplies run out."
Fascinating thought.
One wonders how he reached it. Because it's spelled out in the EO?
Because everyone knows this market challenge will cause shortages?
Or - ??
Back in August, Michigan Public's Tracy Samilton reported some of the back room dealing on these bills.
Importantly, mandating insurance coverage for over the counter birth control negates competitive price drops.
Expect health insurance rates to rise, since this also returns cost burden to insurance premiums and taxpayers.
New state Senate bills would expand insurance coverage of birth control
Bills introduced this week (SB 973, SB 974) in the state Senate would expand what kind of birth control health insurance plans in Michigan would be required to cover.
Federal law requires Medicaid and nearly all private health insurance plans to cover many kinds of contraceptive drugs requiring a prescription, without copays -- but not over the counter types of birth control like the recently approved Opill, or the emergency contraception drug Plan B.
New bills introduced in the state Senate would require Michigan health insurance plans to cover these over-the-counter birth control drugs as well.
The Michigan Association of Health Plans says it supports maintaining access to contraceptive drugs — while it plans to work with the bills' sponsors to better understand the intent of the bills, and evaluate their impact on health insurance cost and affordability.
Meanwhile, these bills (and more) are still on this committee's action list. They might be worth a conversation next time you see a legislator.
One day before Gov. Whitmer's announced free BCP, the Biden Administration proposed a federal rule to do the same thing. Coordinated? Or one-upmanship?
In Michigan, of course, taxpayers actually pick up the tab. In this case, funds from MDHHS's family planning budget, which the legislature expanded this year by 5.6M.
In Washington's plan, we'll still be picking up the tab, just with a larger bureaucracy. On the plus side, the feds operate under rulemaking procedures, and the public comment period is open. Anyone concerned about this can give their two cents.
Morning Brew reported the DC side of the story.
White House wants to make over-the-counter birth control free
Insurers might be required to offer full coverage of OTC birth control pill and other contraceptives.
By Sam Klebanov | October 22, 2024The Biden administration unveiled a proposed rule yesterday that would require private insurers to pick up the tab for all prescriptionless birth control.
Insurance companies are already mandated to offer 100% coverage of some prescription contraceptives (thanks, Obamacare), but the 2010 law doesn’t address over-the-counter birth control pills, which only recently arrived in the US.
Removing barriers to birth control
The FDA approved an OTC birth control pill, Opill, for the first time last year. But Opill sells for $19.99 per month, so many women with private insurance looking for free access to birth control may not be able to get it. The same often goes for prescribed contraceptives: Reproductive rights activists say that some of the latest birth control methods that are associated with fewer side effects aren’t 100% covered by many insurance plans.
Biden’s rule aims to fix this by also requiring insurers to fully cover a greater variety of IUDs and other products that may appear in a sex-ed curriculum.
Looking ahead: The birth control access push comes just two weeks before the presidential election, in which family planning has been a major flashpoint. The next White House occupant will get to decide whether the proposal goes into effect.
Finally, readers will recall that pharmacist-prescribing or "almost over the counter" was proposed for the same drug not long ago.
The third leg of the state-federal-industry tango showed up in a bill package posted here six months ago
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














